Synbiotic Health and its new spin-off NoviaHealth largely focus on developing probiotic ingredients.
Synbiotic Health, a company founded in 2018 focused on microbiome-ingredient research, has launched a new company called NoviaHealth LLC whose focus will be to commercialize probiotics and other dietary supplements. NoviaHealth has exclusive rights to commercialize new discoveries made by Synbiotic Health researchers.
Synbiotic Health largely focuses on R&D for probiotic ingredients. “As a new and independent company, NoviaHealth LLC will provide probiotic concentrates, custom probiotic blends, and turnkey contract development and manufacturing services to the dietary supplement market,” the companies' press release states.
NoviaHealth’s new manufacturing facility and offices will open in Madison, WI, in the second quarter of 2024, it adds. There, the company will provide product concept, co-development, and custom formulation services, with low minimum order quantities, the firms say.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.